Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ferreri

Showing results (11-20 of 453) with videos related to

Pageof 46
Sort By:
Blood|July 2, 2026
EBV and immunodeficiency: the odd couple drawn to the brainAndrés J M Ferreri
Blood|May 27, 2011
How I treat primary CNS lymphomaAndrés J M Ferreri
Chest|March 3, 2011
Activity of clarithromycin in mucosa-associated lymphoid tissue-type lymphomas: antiproliferative drug or simple antibiotic?Andrés J M Ferreri
Idrugs : the Investigational Drugs Journal|April 6, 2006
Hematologic malignancies: from clinical science to clinical practice - 2nd European CongressAndres J M Ferreri
JAMA Oncology|July 17, 2015
Who Is Who in Primary Vitreoretinal Lymphoma?Andrés J M Ferreri
The Lancet. Haematology|April 1, 2016
Bendamustine plus rituximab in MALT lymphomaAndrés J M Ferreri
The Lancet. Oncology|March 15, 2020
Patience and commitment needed to fight very rare tumoursAndrés J M Ferreri
The Lancet. Oncology|May 19, 2019
Targeted therapies make room, anti-CD79b agents are comingAndrés J M Ferreri
The Lancet. Oncology|April 4, 2014
Risk of CNS dissemination in extranodal lymphomasAndrés J M Ferreri
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 30, 2017
Secondary CNS lymphoma: the poisoned needle in the haystackA J M Ferreri
Pageof 46

Showing results (11-20 of 453) with videos related to

Sort By:
Pageof 46
Blood|July 2, 2026
EBV and immunodeficiency: the odd couple drawn to the brainAndrés J M Ferreri
Blood|May 27, 2011
How I treat primary CNS lymphomaAndrés J M Ferreri
Chest|March 3, 2011
Activity of clarithromycin in mucosa-associated lymphoid tissue-type lymphomas: antiproliferative drug or simple antibiotic?Andrés J M Ferreri
Idrugs : the Investigational Drugs Journal|April 6, 2006
Hematologic malignancies: from clinical science to clinical practice - 2nd European CongressAndres J M Ferreri
JAMA Oncology|July 17, 2015
Who Is Who in Primary Vitreoretinal Lymphoma?Andrés J M Ferreri
The Lancet. Haematology|April 1, 2016
Bendamustine plus rituximab in MALT lymphomaAndrés J M Ferreri
The Lancet. Oncology|March 15, 2020
Patience and commitment needed to fight very rare tumoursAndrés J M Ferreri
The Lancet. Oncology|May 19, 2019
Targeted therapies make room, anti-CD79b agents are comingAndrés J M Ferreri
The Lancet. Oncology|April 4, 2014
Risk of CNS dissemination in extranodal lymphomasAndrés J M Ferreri
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 30, 2017
Secondary CNS lymphoma: the poisoned needle in the haystackA J M Ferreri
Pageof 46